Regeneron Pharmaceuticals Inc

REGN
www.regeneron.com
Pharmaceuticals
1m5m15m1h4h1d1w

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD,...
IndustryPharmaceuticalsHeadquarters777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NYPrimary ExchangeNASDAQEmployees15,410Listing DateApr 2, 1991Nettstedwww.regeneron.com

Key Metrics

Markedsverdi$80.80B
P/E18.7x
P/B2.6x
EBITDA$1.42B
EPS$12.23
ROE13.65%
ROA10.37%
Dividend Yield0.00%

Corporate Actions

Earnings ReportSep 30, 2024
FY2024 Q3 earnings reported. Diluted EPS: $11.54.
Earnings ReportDec 31, 2024
FY2024 Q4 earnings reported. Diluted EPS: $8.07.
Earnings ReportDec 31, 2024
FY2024 Q4 earnings reported. Diluted EPS: $38.34.
Ex-DividendFeb 20, 2025
Irregular dividend of $0.88 per share. Ex-dividend date: February 20. Payable: March 20.
Earnings ReportMar 31, 2025
FY2025 Q1 earnings reported. Diluted EPS: $7.27.
Ex-DividendMay 20, 2025
Quarterly dividend of $0.88 per share. Ex-dividend date: May 20. Payable: June 6.
Earnings ReportJun 30, 2025
FY2025 Q2 earnings reported. Diluted EPS: $12.81.
Ex-DividendAug 18, 2025
Quarterly dividend of $0.88 per share. Ex-dividend date: August 18. Payable: September 3.
Earnings ReportSep 30, 2025
FY2025 Q3 earnings reported. Diluted EPS: $13.62.
Ex-DividendNov 20, 2025
Quarterly dividend of $0.88 per share. Ex-dividend date: November 20. Payable: December 5.
Earnings ReportDec 31, 2025
FY2025 Q4 earnings reported. Diluted EPS: $7.86.
Earnings ReportDec 31, 2025
FY2025 Q4 earnings reported. Diluted EPS: $41.48.
Ex-DividendFeb 20, 2026
Quarterly dividend of $0.94 per share. Ex-dividend date: February 20. Payable: March 5.
Earnings ReportMar 31, 2026
FY2026 Q1 earnings reported. Diluted EPS: $6.75.
Ex-DividendMay 20, 2026
Quarterly dividend of $0.94 per share. Ex-dividend date: May 20. Payable: June 4.
Earnings ReportJun 30, 2026
FY2026 Q2 earnings reported. Diluted EPS: $12.23.
Ex-DividendAug 18, 2026
Quarterly dividend of $0.94 per share. Ex-dividend date: August 18. Payable: August 31.

Trade REGN on Bybit

0 ways to get exposure to Regeneron Pharmaceuticals Inc. Pick the one that fits your strategy.

FAQ about Regeneron Pharmaceuticals Inc

What is the current price of Regeneron Pharmaceuticals Inc?

The current price of REGN is shown in the price section above and updated in real time during regular trading hours. If you trade REGN Perpetuals on Bybit, pre-market, post-market, and overnight prices are also available.

How do I trade REGN on Bybit?

Does Regeneron Pharmaceuticals Inc pay dividends?

What is Regeneron Pharmaceuticals Inc's P/E ratio, and what does it mean?

What financial results has Regeneron Pharmaceuticals Inc recently released?

Can I trade REGN 24/7 on Bybit?

What payment methods can I use to buy REGN?

How does buying REGN on Bybit compare to using a traditional broker?

Ansvarsfraskrivelse

The information contained herein is provided for informational purposes only and does not constitute investment, financial, trading, or other professional advice. Trading in digital assets and securities involves substantial risk of loss, including the possible loss of all principal invested. The value of digital assets and securities may be highly volatile, and past performance is not indicative of future results. Market data displayed is sourced from third-party data providers and may be subject to delays or inaccuracies. Bybit does not warrant the accuracy, completeness, or timeliness of any information displayed. All investment decisions are made solely at the investor's own risk. Independent due diligence and consultation with a licensed financial advisor are strongly recommended before making any investment decision.

--
--
Markedsverdi$80.80B
P/B2.6x
P/E18.7x
52-Week High/Low$863.00/$717.65
Dividend Yield0.00%
Dividend FrequencyQuarterly

Trade REGN

News

Rising inflation risks and the Fed’s recent decision to raise borrowing costs have prompted Bank of America to pencil in two more interest-rate increases in South Africa this year.
Bloomberg21m ago
Markets’ Eyes on the FED: FED Member Goolsbee on Inflation, Bessent on Warsh!
49m ago
US Dollar: Oil-driven support as Fed seen hiking – ING
Financia lJuice2h ago
Experts agree: Further US Dollar’s upside hinges on upcoming data and not hawkish Fed prospects
Financia lJuice3h ago
Federal Reserve's Goolsbee: If there is solid evidence that inflation is coming back down to 2%, I have no objection to rate cuts
PANews4h ago